Determinant Multidrug-Resisteant Tuberculosis: A Scoping Review
DOI:
https://doi.org/10.32583/keperawatan.v17i1.1059Keywords:
determinan, MDR-TB, rifampicin isoniazidAbstract
Tuberkulosis yang resistan terhadap obat mengalami peningkatan dari tahun 2020 dan 2021. Beberapa faktor dapat mempengaruhi determinan Multidrug-Resistant Tuberculosis, yaitu pengobatan yang tidak adekuat, kurangnya pemantauan pasien, kepatuhan pasien yang buruk dalam mengonsumsi obat-obatan, dan penyebaran Multidrug-Resistant Tuberculosis di antara populasi yang rentan seperti orang dengan HIV. Tujuan penelitian ini melihat gambaran determinan Multidrug-Resistant Tuberculosis. Metode scoping review melalui tinjuan artikel yang relevan dari database Sciencedirect, Pubmed, scopus, spinger link. Kriteria 5 tahun terakhir publikasi 2018-2023. Kata kunci “determinant” and “mdr tb” and “rifampicin isoniazid”. Pencarian dilakukan pada referensi full text dan full akses, artikel bahasa inggris, jumlah artikel yang digunakan 5 artikel. Hasil Studi tentang determinan Multidrug-Resistant Tuberculosis mencakup beberapa faktor yang dapat mempengaruhi risiko seseorang terkena Multidrug-Resistant Tuberculosis. Faktor-faktor ini dapat dibagi menjadi beberapa kategori, termasuk demografi (usia, pekerjaan, dan pendapatan) lingkungan (tinggal dipedesaan, rumah yang mempunyai kamar kurang dari 3, dan stigma sosial) riwayat penyakit sebelumnya (pengobatan sebelumnya, kontak dengan pendeita TB, pengobatan yang tidak sesuai, HIV, TB) prilaku (meminum alkohol, merokok, konsultasi ke dukun) dan faktor bioloogis melihat indeks massa tubuh. Kesimpulan Dalam rangka mengatasi MDR-TB, diperlukan upaya untuk memperkuat sistem kesehatan, meningkatkan pemantauan dan pengawasan pengobatan TB, serta meningkatkan pemahaman dan kesadaran tentang TB dan cara menghindari penyebarannya.
References
Admassu, Fantahun, Ermias Abera, Addisalem Gizachew, and Tagesse Sedoro. 2023. “Risk Factors of Multidrug Resistant Tuberculosis among Patients with Tuberculosis at Selected Multidrug Resistance Treatment Initiative Centres in Southern Ethiopia : A Case- Control Study.” : 1–6.
Anisah, Dyah Wulan Sumekar, and Endang Budiarti. 2021. “Hubungan Demografi Dan Komorbid Dengan Kejadian Tuberkulosis Resisten Obat (TB RO).” Jurnal Ilmiah Kesehatan Sandi Husada 10(2): 568–74.
Badgeba, A et al. 2022. “Determinants of Multidrug-Resistant Mycobacterium Tuberculosis Infection: A Multicenter Study from Southern Ethiopia.” Infection and Drug Resistance 15: 3523–35.
Badgeba, Abdulkerim, Mulugeta Shegaze Shimbre, and Mathewos Alemu Gebremichael. 2022. “Determinants of Multidrug-Resistant Mycobacterium Tuberculosis Infection : A Multicenter Study from Southern Ethiopia.” (June): 3523–35.
Bagcchi, Sanjeet. 2023. “WHO’s Global Tuberculosis Report 2022.” The Lancet Microbe 4(1): e20.
Bawonte, Trivianto G., Christi D. Mambo, and Angelina S. R. Masengi. 2021. “Faktor-Faktor Yang Mempengaruhi Tuberculosis Multidrug Resistance (TB MDR).” Jurnal e-Biomedik 9(1): 117–25.
Baya, Bocar, Chad J Achenbach, Bourahima Kone, Yacouba Toloba, Djeneba K Dabitao, et al. 2019. “Clinical Risk Factors Associated with Multidrug-Resistant Tuberculosis ( MDR-TB ) in Mali.” International Journal of Infectious Diseases 81: 149–55.
Baya, Bocar, Chad J Achenbach, Bourahima Kone, Yacouba Toloba, K Djeneba, et al. 2019. “Clinical Risk Factors Associated with Multidrug-Resistant Tuberculosis (MDR-TB) in Mali.” : 149–55.
Carolia, Novita, and Annisa Mardhiyyah. 2016. “Multi Drug Resistant Tuberculosis Pada Pasien Drop Out Dan Tatalaksana OAT Lini Kedua.” Jurnal Majority 5(2): 11–16. https://juke.kedokteran.unila.ac.id/index.php/majority/article/view/1070.
Cecile, Djuikoue I et al. 2022. “Risk Factors Associated to Multidrug ‑ Resistant Tuberculosis in Patients Attending the Deido District Hospital of Douala – Cameroon.”
DKK. 2021. “DINAS KESEHATAN PROVINSI.”
Fikre, Absera, Tsegaye Tewelde, and Tamrat Shaweno. 2019. “Determinants of Multi-Drug Resistant Tuberculosis among Tuberculosis Patients in Southern Ethiopia: A Case Control Study.” J Med Bacteriol 8(1): 1–12.
Getahun, Y, Getahun Yeshiwas Ambaye, Gebiyaw Wudie Tsegaye, and Background Multi-drug Resistant Tuberculosis Mdr-tb. 2021. “Factors Associated with Multi-Drug Resistant Tuberculosis among TB Patients in Selected Treatment Centers of Amhara Region : A Case-Control Study.”
Girum, Tadele et al. 2018. “Epidemiology of Multidrug-Resistant Tuberculosis ( MDR-TB ) in Ethiopia : A Systematic Review and Meta-Analysis of the Prevalence , Determinants and Treatment Outcome.” : 1–12.
Gobena, Dabesa et al. 2018. “Predictor of Multidrug Resistant Tuberculosis in Southwestern Part of Ethiopia : A Case Control Study.” Annals of Clinical Microbiology and Antimicrobials: 1–7.
Hidayathillah, Ariska.P, and Chatarina U. Wahyuni. 2018. “Model Pencegahan Tuberkulosis Resisten Obat (TB – MDR) Untuk Menurunkan Angka Kejadian TB-MDR.” Prosiding Seminar Nasional GERMAS 2018 1(1): 21–29. http://journal2.unusa.ac.id/index.php/SNG/article/view/421.
Jie, Anita D. 2022. “Ciri Ciri TB MDR.”
Koo, Hyeon-kyoung et al. 2020. “Prediction of Treatment Failure and Compliance in Patients with Tuberculosis.” : 1–7.
Lucia Duniawuri. 2023. “Penyebab Penyakit TB MDR.”
Mesfin, Eyob Abera et al. 2018. “Drug-Resistance Patterns of Mycobacterium Tuberculosis Strains and Associated Risk Factors among Multi Drug-Resistant Tuberculosis Suspected Patients from Ethiopia.” 110: 1–16.
Sambas, Khatib et al. 2020. “Prevalence and Determinants of Multidrug- Resistant Tuberculosis in Makkah , Saudi Arabia.” : 4031–38.
Soesanti, and Abd Hakim Husen. 2022. “Analisis Faktor Determinan Demografi Dengan Kejadian Tuberculosis Multidrug Resistant Tuberculosis (MDR-TB).” Jurnal Nursing Update 13(2): 42–47.
Stosic, Maja et al. 2018. “Risk Factors for Multidrug-Resistant Tuberculosis among Tuberculosis Patients in Serbia: A Case-Control Study.” BMC Public Health 18(1): 1–8.
Timire, Collins et al. 2019. “International Journal of Infectious Diseases Prevalence of Drug-Resistant Tuberculosis in Zimbabwe : A Health Facility-Based Cross-Sectional Survey.” International Journal of Infectious Diseases 87: 119–25.
Westphaln, Kristi K et al. 2021. “MethodsX From Arksey and O ’ Malley and Beyond : Customizations to Enhance a Team-Base d , Mixe d Approach to Scoping Review Methodology.” MethodsX 8: 101375.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Jurnal Keperawatan
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
